MedPath

Effect of Tea tree oil in treatment of Meibomian gland dysfunctio

Phase 3
Conditions
Meibomian gland dysfunction.
Meibomian gland dysfunction of eyelid
H02.88
Registration Number
IRCT20201219049753N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Adult patients aged 18 to 70 years with meibomian gland dysfunction diagnosis in slit-lamp examination

Exclusion Criteria

Systemic medications affecting tear production (antihistamines, antidepressants and etc.)
Contact lenses
Eyelid malfunction such as lagophthalmous
History of ocular surgery
Other ocular diseases involving ocular surface (Stevens-Johnson, Sjogren's syndrome, chemical damage, history of head radiation)
Systemic diseases involving ocular surface ( Diabetes mellitus, rosacea, neurologic diseases)
Infectious keratoconjunctivitis
Any topical medication such as steroids during last four weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath